Skip to main content
. 2021 Jan 12;12:279. doi: 10.1038/s41467-020-20542-0

Fig. 2. Preparation of remdesivir-containing RNA.

Fig. 2

a Scheme of the synthesis of 5ʹ-O-DMT-2ʹ-O-TBDMS-protected 3ʹ-cyanoethyl diisopropyl phosphoramidite (Rem-PA), which was used to synthesize RNA oligos with remdesivir monophosphate (RMP) at defined positions. b Analysis of RMP-containing RNA by denaturing HPLC confirms the presence of RMP. c Analysis of the RMP-containing RNA by LC-MS after digestion into mononucleosides confirms the presence of RMP. d Minimal RNA template-product scaffold with RMP (R) or AMP (A) in a synthesized RNA oligonucleotide product strand. e The presence of RMP in a synthesized RNA oligonucleotide inhibits RNA extension by RdRp on the minimal RNA scaffold (d). Source data are provided as a Source Data file.